Atossa TherapeuticsATOS
13F holders, Q2 2025 (June 30)1holders
$0.80avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Atossa Therapeutics Inc. (ATOS) in their 13F filings. The largest holder was Essential Partners LLC ($12).
- Company
- Atossa Therapeutics Inc.
- CUSIP
- 04962H704
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
No earlier quarter to compare with.
Ownership 1 holders
| Essential Partners LLC | 0.00% | — | 15 | $12 |
"% of holder's portfolio" is ATOS's weight in each manager's 13F, not the share of Atossa Therapeutics Inc. the manager owns.